3 Month Study of Alocross Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 11, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Dry Eye Syndromes

Interventions

DEVICE

Alocross 0.2% Unit Dose

Eye Drops

DEVICE

Vismed

Eye drops

Trial Locations (6)

Hopitaux Universitaires Paris-Sud - Hopital Bicetre, Le Kremlin-Bicêtre

Chru Brest Hopital Morvan, Brest

Cabinet Liberal, La Rochefoucauld

Hopital Edouard Herriot - Pavillon C, Lyon

Institut Ophtalmologique Ouest Jules Verne, Nantes

Hopital Necker - Ophtalmologie, Paris

All Listed Sponsors

lead

Santen SAS

INDUSTRY